Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
McKesson

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Bacitracin zinc; polymyxin b sulfate - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic drug sources for bacitracin zinc; polymyxin b sulfate and what is the scope of freedom to operate?

Bacitracin zinc; polymyxin b sulfate is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmafair, Monarch Pharms, and Naska, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for bacitracin zinc; polymyxin b sulfate. Seven suppliers are listed for this compound.

Summary for bacitracin zinc; polymyxin b sulfate
Recent Clinical Trials for bacitracin zinc; polymyxin b sulfate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)N/A
Glaxo WellcomeN/A

See all bacitracin zinc; polymyxin b sulfate clinical trials

Pharmacology for bacitracin zinc; polymyxin b sulfate

US Patents and Regulatory Information for bacitracin zinc; polymyxin b sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms POLYSPORIN bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 061229-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Akorn BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 064028-001 Jan 30, 1995 AT RX No No   Start Trial   Start Trial   Start Trial
Perrigo Co Tennessee BACITRACIN ZINC AND POLYMYXIN B SULFATE bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 065022-001 Feb 27, 2002 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Mallinckrodt
McKinsey
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.